Inhibitors of alpha-synuclein oligomerization and toxicity: a future therapeutic strategy for Parkinson's disease and related disorders.
Exp Brain Res
; 173(2): 223-33, 2006 Aug.
Article
in En
| MEDLINE
| ID: mdl-16733698
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Parkinson Disease
/
Alpha-Synuclein
/
Antiparkinson Agents
Limits:
Animals
/
Humans
Language:
En
Journal:
Exp Brain Res
Year:
2006
Document type:
Article
Affiliation country:
Emiratos Árabes Unidos
Country of publication:
Alemania